|
|
|
|
|
by 22c
1687 days ago
|
|
Based on this, it should be expected that the 2% figure you quoted would increase over time. I would say in Australia a lot of people are still in the "honeymoon phase" of immunity where it hasn't started to significantly wane amongst the population of the fully vaccinated. |
|
edit: to quote specifics from the study
> Our findings are in line with findings from the randomized trial of the BNT162b2 vaccine, which showed a reduction in vaccine efficacy against symptomatic infection from 96% in the first 2 months after vaccination to 84% at 4 to 7 months after vaccination, when averaged over all age groups combined